{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T19:44:01Z","timestamp":1778960641722,"version":"3.51.4"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>This review critically considers the impact of the COVID-19 pandemic on global travel and the practice of travel medicine, highlights key innovations that have facilitated the resumption of travel, and anticipates how travel medicine providers should prepare for the future of international travel.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>Since asymptomatic transmission of the virus was first recognized in March 2020, extensive efforts have been made to characterize the pattern and dynamics of SARS-CoV-2 transmission aboard commercial aircraft, cruise ships, rail and bus transport, and in mass gatherings and quarantine facilities. Despite the negative impact of further waves of COVID-19 driven by the more transmissible Omicron variant, rapid increases of international tourist arrivals are occurring and modeling anticipates further growth. Mitigation of spread requires an integrated approach that combines masking, physical distancing, improving ventilation, testing, and quarantine. Vaccines and therapeutics have played a significant role in reopening society and accelerating the resumption of travel and further therapeutic innovation is likely.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>COVID-19 is likely to persist as an endemic infection, and surveillance will assume an even more important role. The pandemic has provided an impetus to advance technology for telemedicine, to adopt mobile devices and GPS in contact tracing, and to apply digital applications in research. The future of travel medicine should continue to harness these novel platforms in the clinical, research, and educational arenas.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11908-022-00784-3","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T12:02:45Z","timestamp":1659614565000},"page":"129-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Travel in the Time of COVID: A Review of International Travel Health in a Global Pandemic"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5987-1658","authenticated-orcid":false,"given":"Gerard T.","family":"Flaherty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davidson H.","family":"Hamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"key":"784_CR1","doi-asserted-by":"publisher","unstructured":"World Tourism Organization. International tourism highlights, 2020 edition. UNWTO, Madrid. 2021. https:\/\/doi.org\/10.18111\/9789284422456.","DOI":"10.18111\/9789284422456"},{"issue":"2","key":"784_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jtm\/taaa015","volume":"27","author":"ME Wilson","year":"2020","unstructured":"Wilson ME, Chen LH. Travelers give wings to novel coronavirus (2019-nCoV). J Travel Med. 2020;27(2):1\u20133. https:\/\/doi.org\/10.1093\/jtm\/taaa015.","journal-title":"J Travel Med"},{"key":"784_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taaa085","author":"LH Chen","year":"2020","unstructured":"Chen LH, Freedman DO, Visser LG. COVID-19 immunity passport to ease travel restrictions? J Travel Med. 2020. https:\/\/doi.org\/10.1093\/jtm\/taaa085.","journal-title":"J Travel Med"},{"key":"784_CR4","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Wilson ME, Chen LH. Re-starting travel in the era of COVID-19: preparing anew. J Travel Med 2020;27(5):taaa108. Practical guidance for travel medicine practitioners regarding the assessment of the risk of SARS-CoV-2 in the pre-travel consultation.","DOI":"10.1093\/jtm\/taaa108"},{"issue":"2","key":"784_CR5","doi-asserted-by":"publisher","first-page":"taaa241","DOI":"10.1093\/jtm\/taaa241","volume":"28","author":"LH Chen","year":"2021","unstructured":"Chen LH, Steffen R. SARS-CoV-2 testing to assure safety in air travel. J Travel Med. 2021;28(2):taaa241.","journal-title":"J Travel Med"},{"issue":"104","key":"784_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijid.2021.01.039","volume":"20","author":"E Petersen","year":"2021","unstructured":"Petersen E, Lucey D, Blumberg L, Kramer LD, Al-Abri S, Lee SS, Pinto TCA, Obiero CW, Rodriguez-Morales AJ, Yapi R, Abubakar A, Tambyah PA, Holmes A, Chen LH. COVID-19 vaccines under the International Health Regulations - we must use the WHO International Certificate of Vaccination or Prophylaxis. Int J Infect Dis. 2021;20(104):175\u20137. https:\/\/doi.org\/10.1016\/j.ijid.2021.01.039.","journal-title":"Int J Infect Dis"},{"key":"784_CR7","doi-asserted-by":"publisher","unstructured":"\u2022 Chen LH, Petersen E, Blumberg L, Piyaphanee W, Steffen R. COVID-19 health passes: current status and prospects for a global approach. J Travel Med. 2021;28(7):taab118. https:\/\/doi.org\/10.1093\/jtm\/taab118. Authoritative perspective on the use of digital health passports at international borders.","DOI":"10.1093\/jtm\/taab118"},{"key":"784_CR8","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Khatib AN, Carvalho AM, Primavesi R, To K, Poirier V. Navigating the risks of flying during COVID-19: a review for safe air travel. J Travel Med. 2020;27(8):taaa212. https:\/\/doi.org\/10.1093\/jtm\/taaa212. Review of the in-flight transmission risks of commercial air travel, with recommendations about the risks of flying during the pandemic.","DOI":"10.1093\/jtm\/taaa212"},{"issue":"5","key":"784_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/QCO.0000000000000771","volume":"34","author":"AN Khatib","year":"2021","unstructured":"Khatib AN, McGuinness S, Wilder-Smith A. COVID-19 transmission and the safety of air travel during the pandemic: a scoping review. Curr Opin Infect Dis. 2021;34(5):415\u201322. https:\/\/doi.org\/10.1097\/QCO.0000000000000771.","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"784_CR10","doi-asserted-by":"publisher","first-page":"taaa149","DOI":"10.1093\/jtm\/taaa149","volume":"27","author":"C Hatz","year":"2020","unstructured":"Hatz C, B\u00fchler S, Farnham A. The COVID-19 pandemic offers a key moment to reflect on travel medicine practice. J Travel Med. 2020;27(8):taaa149. https:\/\/doi.org\/10.1093\/jtm\/taaa149.","journal-title":"J Travel Med"},{"issue":"2","key":"784_CR11","doi-asserted-by":"publisher","first-page":"taaa148","DOI":"10.1093\/jtm\/taaa148","volume":"28","author":"DR Shlim","year":"2021","unstructured":"Shlim DR, Connor BA, Taylor DN. What will travel medicine look like in the COVID-19 pandemic era? J Travel Med. 2021;28(2):taaa148. https:\/\/doi.org\/10.1093\/jtm\/taaa148.","journal-title":"J Travel Med"},{"issue":"8","key":"784_CR12","doi-asserted-by":"publisher","first-page":"taaa220","DOI":"10.1093\/jtm\/taaa220","volume":"27","author":"GT Flaherty","year":"2020","unstructured":"Flaherty GT, Acosta RW, Visser JT, Coyle CM, Chen LH. Learning in lockdown: preparing for the inaugural virtual conference of the International Society of Travel Medicine. J Travel Med. 2020;27(8):taaa220. https:\/\/doi.org\/10.1093\/jtm\/taaa220.","journal-title":"J Travel Med"},{"key":"784_CR13","doi-asserted-by":"publisher","unstructured":"\u2022 Acosta RW, Visser JT, Chen LH, Leggat PA, Flaherty GT. Adaptation of travel medicine practitioners to the COVID-19 pandemic: a cross-sectional survey of ISTM members. J Travel Med. 2022;taac032. https:\/\/doi.org\/10.1093\/jtm\/taac032. An insightful report on the response of the travel medicine community to the COVID-19 pandemic.","DOI":"10.1093\/jtm\/taac032"},{"key":"784_CR14","unstructured":"World Tourism Organization. Impact assessment of the COVID-19 outbreak on international tourism. 2022. Available at: https:\/\/www.unwto.org\/impact-assessment-of-the-covid-19-outbreak-on-international-tourism. (last accessed 06 May 2022)."},{"issue":"8","key":"784_CR15","doi-asserted-by":"publisher","first-page":"taaa150","DOI":"10.1093\/jtm\/taaa150","volume":"27","author":"GT Flaherty","year":"2020","unstructured":"Flaherty GT, Nasir N. Reiseangst: travel anxiety and psychological resilience during and beyond the COVID-19 pandemic. J Travel Med. 2020;27(8):taaa150. https:\/\/doi.org\/10.1093\/jtm\/taaa150.","journal-title":"J Travel Med"},{"issue":"2","key":"784_CR16","doi-asserted-by":"publisher","first-page":"taz088","DOI":"10.1093\/jtm\/taz088","volume":"27","author":"GT Flaherty","year":"2020","unstructured":"Flaherty GT, Holmes A. Will flight shaming influence the future of air travel? J Travel Med. 2020;27(2):taz088. https:\/\/doi.org\/10.1093\/jtm\/taz088.","journal-title":"J Travel Med"},{"issue":"1","key":"784_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.56026\/imu.15.1.1","volume":"15","author":"GT Flaherty","year":"2021","unstructured":"Flaherty GT, Vyas V, Browne F. Quo vadis? Reflections on the future direction of travel medicine practice and research. IeJSME. 2021;15(1):1\u20134.","journal-title":"IeJSME"},{"issue":"8","key":"784_CR18","doi-asserted-by":"publisher","first-page":"taab140","DOI":"10.1093\/jtm\/taab140","volume":"28","author":"RM Mangan","year":"2021","unstructured":"Mangan RM, Flaherty GT. The advent of social media influencer tourism: travel health risks and opportunities. J Travel Med. 2021;28(8):taab140. https:\/\/doi.org\/10.1093\/jtm\/taab140.","journal-title":"J Travel Med"},{"key":"784_CR19","doi-asserted-by":"publisher","unstructured":"\u2022 Klinger C, Burns J, Movsisyan A, et al. Unintended health and societal consequences of international travel measures during the COVID-19 pandemic: a scoping review. J Travel Med. 2021;28(7):taab123. https:\/\/doi.org\/10.1093\/jtm\/taab123. Scoping review of empirical studies on the collateral effects, both beneficial and harmful, of international travel restrictions relating to the COVID-19 pandemic.","DOI":"10.1093\/jtm\/taab123"},{"key":"784_CR20","doi-asserted-by":"crossref","unstructured":"Hu Y, Xu CL, Tu M. Family-mediated migration infrastructure: Chinese international students and parents navigating (im)mobilities during the COVID-19 pandemic. Chin Sociol Rev. 2020.","DOI":"10.1080\/21620555.2020.1838271"},{"key":"784_CR21","first-page":"1446","volume":"54","author":"PN Martuscelli","year":"2020","unstructured":"Martuscelli PN. How are refugees affected by Brazilian responses to COVID-19? Rev Adm P\u00fablica. 2020;54:1446\u201357.","journal-title":"Rev Adm P\u00fablica"},{"key":"784_CR22","doi-asserted-by":"publisher","first-page":"6741","DOI":"10.3390\/ijerph17186741","volume":"17","author":"A Radic","year":"2020","unstructured":"Radic A, L\u00fcck M, Ariza-Montes A, Han H. Fear and trembling of cruise ship employees: psychological effects of the COVID-19 pandemic. Int J Environ Res Public Health. 2020;17:6741.","journal-title":"Int J Environ Res Public Health"},{"key":"784_CR23","doi-asserted-by":"publisher","first-page":"144148","DOI":"10.1016\/j.scitotenv.2020.144148","volume":"761","author":"H Zhang","year":"2021","unstructured":"Zhang H, Lin Y, Wei S, et al. Global association between satellite-derived nitrogen dioxide (NO2) and lockdown policies under the COVID-19 pandemic. Sci Total Environ. 2021;761:144148.","journal-title":"Sci Total Environ"},{"key":"784_CR24","unstructured":"CNN Travel. Deserted Venice contemplates a future without tourist hordes after Covid-19. 2020. Available at: https:\/\/edition.cnn.com\/travel\/article\/venice-future-covid-19\/index.html. Accessed 24 June 2022."},{"key":"784_CR25","doi-asserted-by":"publisher","first-page":"100255","DOI":"10.1016\/j.puhip.2022.100255","volume":"3","author":"G Barry","year":"2022","unstructured":"Barry G, McCarney C, Farrelly M, Breathnach R, Mooney C, More SJ. Rapid antigen testing for SARS-CoV-2 infection in a university setting in Ireland: learning from a 6-week pilot study. Public Health Pract (Oxf). 2022;3:100255. https:\/\/doi.org\/10.1016\/j.puhip.2022.100255.","journal-title":"Public Health Pract (Oxf)"},{"issue":"7","key":"784_CR26","doi-asserted-by":"publisher","first-page":"taab085","DOI":"10.1093\/jtm\/taab085","volume":"28","author":"MA Qahtani","year":"2021","unstructured":"Qahtani MA, Yang CWT, Lazosky L, et al. SARS-CoV-2 rapid antigen testing for departing passengers at Vancouver International Airport. J Travel Med. 2021;28(7):taab085. https:\/\/doi.org\/10.1093\/jtm\/taab085.","journal-title":"J Travel Med"},{"issue":"8","key":"784_CR27","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.3201\/eid2608.201229","volume":"26","author":"RJJ Soo","year":"2020","unstructured":"Soo RJJ, Chiew CJ, Ma S, Pung R, Lee V. Decreased influenza incidence under COVID-19 control measures. Singapore Emerg Infect Dis. 2020;26(8):1933\u20135. https:\/\/doi.org\/10.3201\/eid2608.201229.","journal-title":"Singapore Emerg Infect Dis"},{"issue":"5","key":"784_CR28","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3390\/v14051071","volume":"14","author":"C Achangwa","year":"2022","unstructured":"Achangwa C, Park H, Ryu S, Lee MS. Collateral impact of public health and social measures on respiratory virus activity during the COVID-19 pandemic 2020\u20132021. Viruses. 2022;14(5):1071. https:\/\/doi.org\/10.3390\/v14051071.","journal-title":"Viruses"},{"issue":"8","key":"784_CR29","doi-asserted-by":"publisher","first-page":"taaa134","DOI":"10.1093\/jtm\/taaa134","volume":"27","author":"R de Miguel Buckley","year":"2020","unstructured":"de Miguel Buckley R, Trigo E, de la Calle-Prieto F, Arsuaga M, D\u00edaz-Men\u00e9ndez M. Social distancing to combat COVID-19 led to a marked decrease in food-borne infections and sexually transmitted diseases in Spain. J Travel Med. 2020;27(8):taaa134. https:\/\/doi.org\/10.1093\/jtm\/taaa134.","journal-title":"J Travel Med"},{"issue":"8","key":"784_CR30","doi-asserted-by":"publisher","first-page":"taaa180","DOI":"10.1093\/jtm\/taaa180","volume":"27","author":"R Steffen","year":"2020","unstructured":"Steffen R, Lautenschlager S, Fehr J. Travel restrictions and lockdown during the COVID-19 pandemic-impact on notified infectious diseases in Switzerland. J Travel Med. 2020;27(8):taaa180. https:\/\/doi.org\/10.1093\/jtm\/taaa180.","journal-title":"J Travel Med"},{"issue":"5","key":"784_CR31","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S1473-3099(22)00025-1","volume":"22","author":"Y Chen","year":"2022","unstructured":"Chen Y, Li N, Louren\u00e7o J, et al. Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling study. Lancet Infect Dis. 2022;22(5):657\u201367. https:\/\/doi.org\/10.1016\/S1473-3099(22)00025-1.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"784_CR32","doi-asserted-by":"publisher","first-page":"taab159","DOI":"10.1093\/jtm\/taab159","volume":"28","author":"L Schubert","year":"2021","unstructured":"Schubert L, Thurnher PMM, Machold PK, Tobudic PS, Winkler PS. Pandemic-related delay of falciparum malaria diagnosis in a traveller leading to cerebral malaria. J Travel Med. 2021;28(8):taab159. https:\/\/doi.org\/10.1093\/jtm\/taab159.","journal-title":"J Travel Med"},{"issue":"1","key":"784_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.17269\/s41997-021-00601-9","volume":"113","author":"DID Lee","year":"2022","unstructured":"Lee DID, Vanderhout S, Aglipay M, et al. Delay in childhood vaccinations during the COVID-19 pandemic. Can J Public Health. 2022;113(1):126\u201334. https:\/\/doi.org\/10.17269\/s41997-021-00601-9.","journal-title":"Can J Public Health"},{"issue":"7","key":"784_CR34","doi-asserted-by":"publisher","first-page":"taaa144","DOI":"10.1093\/jtm\/taaa144","volume":"27","author":"A Hillis","year":"2020","unstructured":"Hillis A, Leavey C, Kewley S, Church S, Van Hout MC. Sex tourism, disease migration and COVID-19: lessons learnt and best practices moving forward. J Travel Med. 2020;27(7):taaa144. https:\/\/doi.org\/10.1093\/jtm\/taaa144.","journal-title":"J Travel Med"},{"issue":"10","key":"784_CR35","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1056\/NEJMc2001468","volume":"382","author":"C Rothe","year":"2020","unstructured":"Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382(10):970\u20131. https:\/\/doi.org\/10.1056\/NEJMc2001468.","journal-title":"N Engl J Med"},{"issue":"7","key":"784_CR36","doi-asserted-by":"publisher","first-page":"taab133","DOI":"10.1093\/jtm\/taab133","volume":"28","author":"EC Rosca","year":"2021","unstructured":"Rosca EC, Heneghan C, Spencer EA, et al. Transmission of SARS-CoV-2 associated with aircraft travel: a systematic review. J Travel Med. 2021;28(7):taab133. https:\/\/doi.org\/10.1093\/jtm\/taab133.","journal-title":"J Travel Med"},{"issue":"1","key":"784_CR37","doi-asserted-by":"publisher","first-page":"2002113","DOI":"10.2807\/1560-7917.ES.2022.27.1.2002113","volume":"27","author":"KS Willebrand","year":"2022","unstructured":"Willebrand KS, Pischel L, Malik AA, Jenness SM, Omer SB. A review of COVID-19 transmission dynamics and clinical outcomes on cruise ships worldwide, January to October 2020. Euro Surveill. 2022;27(1):2002113. https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.1.2002113.","journal-title":"Euro Surveill"},{"key":"784_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taac057","author":"S Ngeh","year":"2022","unstructured":"Ngeh S, Vogt F, Sikazwe CT, et al. Travel-associated SARS-CoV-2 transmission documented with whole genome sequencing following a long-haul international flight. J Travel Med. 2022. https:\/\/doi.org\/10.1093\/jtm\/taac057.","journal-title":"J Travel Med"},{"issue":"12","key":"784_CR39","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.3201\/eid2612.203910","volume":"26","author":"H Speake","year":"2020","unstructured":"Speake H, Phillips A, Chong T, et al. Flight-associated transmission of severe acute respiratory syndrome coronavirus 2 corroborated by whole-genome sequencing. Emerg Infect Dis. 2020;26(12):2872\u201380. https:\/\/doi.org\/10.3201\/eid2612.203910.","journal-title":"Emerg Infect Dis"},{"key":"784_CR40","doi-asserted-by":"publisher","first-page":"102285","DOI":"10.1016\/j.tmaid.2022.102285","volume":"47","author":"CT Wang","year":"2022","unstructured":"Wang CT, Xu JC, Fu SC, Chao CYH. Airborne infection risk of nearby passengers in a cabin environment and implications for infection control. Travel Med Infect Dis. 2022;47:102285. https:\/\/doi.org\/10.1016\/j.tmaid.2022.102285.","journal-title":"Travel Med Infect Dis"},{"issue":"5","key":"784_CR41","doi-asserted-by":"publisher","first-page":"taaa116","DOI":"10.1093\/jtm\/taaa116","volume":"27","author":"W Ahmed","year":"2020","unstructured":"Ahmed W, Bertsch PM, Angel N, et al. Detection of SARS-CoV-2 RNA in commercial passenger aircraft and cruise ship wastewater: a surveillance tool for assessing the presence of COVID-19 infected travellers. J Travel Med. 2020;27(5):taaa116. https:\/\/doi.org\/10.1093\/jtm\/taaa116.","journal-title":"J Travel Med"},{"issue":"3","key":"784_CR42","doi-asserted-by":"publisher","first-page":"taac004","DOI":"10.1093\/jtm\/taac004","volume":"29","author":"M Kitajima","year":"2022","unstructured":"Kitajima M, Murakami M, Iwamoto R, Katayama H, Imoto S. COVID-19 wastewater surveillance implemented in the Tokyo 2020 Olympic and Paralympic Village. J Travel Med. 2022;29(3):taac004. https:\/\/doi.org\/10.1093\/jtm\/taac004.","journal-title":"J Travel Med"},{"issue":"12","key":"784_CR43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.15585\/mmwr.mm6912e3","volume":"69","author":"LF Moriarty","year":"2020","unstructured":"Moriarty LF, Plucinski MM, Marston BJ, et al. Public health responses to COVID-19 outbreaks on cruise ships - worldwide, February-March 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):347\u201352. https:\/\/doi.org\/10.15585\/mmwr.mm6912e3.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"784_CR44","doi-asserted-by":"publisher","first-page":"e448","DOI":"10.1093\/cid\/ciaa1180","volume":"72","author":"MM Plucinski","year":"2021","unstructured":"Plucinski MM, Wallace M, Uehara A, et al. Coronavirus disease 2019 (COVID-19) in Americans aboard the Diamond Princess cruise ship. Clin Infect Dis. 2021;72(10):e448\u201357. https:\/\/doi.org\/10.1093\/cid\/ciaa1180.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"784_CR45","doi-asserted-by":"publisher","first-page":"taaa030","DOI":"10.1093\/jtm\/taaa030","volume":"27","author":"J Rockl\u00f6v","year":"2020","unstructured":"Rockl\u00f6v J, Sj\u00f6din H, Wilder-Smith A. COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures. J Travel Med. 2020;27(3):taaa030. https:\/\/doi.org\/10.1093\/jtm\/taaa030.","journal-title":"J Travel Med"},{"key":"784_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijid.2022.02.025","volume":"118","author":"K Gravningen","year":"2022","unstructured":"Gravningen K, Henriksen S, Hungnes O, et al. Risk factors, immune response and whole-genome sequencing of SARS-CoV-2 in a cruise ship outbreak in Norway. Int J Infect Dis. 2022;118:10\u201320. https:\/\/doi.org\/10.1016\/j.ijid.2022.02.025.","journal-title":"Int J Infect Dis"},{"issue":"11","key":"784_CR47","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.3201\/eid2611.203299","volume":"26","author":"NC Khanh","year":"2020","unstructured":"Khanh NC, Thai PQ, Quach HL, et al. Transmission of SARS-CoV 2 during long-haul flight. Emerg Infect Dis. 2020;26(11):2617\u201324. https:\/\/doi.org\/10.3201\/eid2611.203299.","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"784_CR48","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.3201\/eid2611.203254","volume":"26","author":"EM Choi","year":"2020","unstructured":"Choi EM, Chu DKW, Cheng PKC, et al. In-flight transmission of SARS-CoV-2. Emerg Infect Dis. 2020;26(11):2713\u20136. https:\/\/doi.org\/10.3201\/eid2611.203254.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"784_CR49","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3201\/eid2705.210514","volume":"27","author":"N Eichler","year":"2021","unstructured":"Eichler N, Thornley C, Swadi T, et al. Transmission of severe acute respiratory syndrome coronavirus 2 during border quarantine and air travel, New Zealand (Aotearoa). Emerg Infect Dis. 2021;27(5):1274\u20138. https:\/\/doi.org\/10.3201\/eid2705.210514.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"784_CR50","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3201\/eid2703.204714","volume":"27","author":"T Swadi","year":"2021","unstructured":"\u2022 Swadi T, Geoghegan JL, Devine T, et al. Genomic evidence of in-flight transmission of SARS-CoV-2 despite predeparture testing. Emerg Infect Dis. 2021;27(3):687\u201393. https:\/\/doi.org\/10.3201\/eid2703.204714. Report of seven cases of SARS-CoV-2 in a managed isolation and quarantine setting in New Zealand.","journal-title":"Emerg Infect Dis"},{"key":"784_CR51","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.puhe.2022.01.004","volume":"204","author":"PF White","year":"2022","unstructured":"White PF, Boland M, O\u2019Sullivan MB, et al. Transmission of SARS-CoV-2 arising from international flights arriving in Ireland in December 2020: a descriptive analysis using national surveillance data. Public Health. 2022;204:49\u201353. https:\/\/doi.org\/10.1016\/j.puhe.2022.01.004.","journal-title":"Public Health"},{"issue":"8","key":"784_CR52","doi-asserted-by":"publisher","first-page":"taab149","DOI":"10.1093\/jtm\/taab149","volume":"28","author":"V Dhanasekaran","year":"2021","unstructured":"Dhanasekaran V, Edwards KM, Xie R, et al. Air travel-related outbreak of multiple SARS-CoV-2 variants. J Travel Med. 2021;28(8):taab149. https:\/\/doi.org\/10.1093\/jtm\/taab149.","journal-title":"J Travel Med"},{"issue":"7","key":"784_CR53","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3201\/eid2807.212466","volume":"28","author":"F Hogarth","year":"2022","unstructured":"\u2022 Hogarth F, Coffey P, Goddard L, et al. Genomic evidence of in-flight SARS-CoV-2 transmission, India to Australia, April 2021. Emerg Infect Dis. 2022;28(7):1527\u201330. https:\/\/doi.org\/10.3201\/eid2807.212466. Epidemiologic and genomic investigation suggesting SARS-CoV-2 transmission despite mandatory mask use and pre-departure testing.","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"784_CR54","doi-asserted-by":"publisher","first-page":"taab180","DOI":"10.1093\/jtm\/taab180","volume":"29","author":"A Molero-Salinas","year":"2022","unstructured":"Molero-Salinas A, Rico-Luna C, Losada C, et al. High SARS-CoV-2 viral load in travellers arriving in Spain with a negative COVID-19 test prior to departure. J Travel Med. 2022;29(3):taab180. https:\/\/doi.org\/10.1093\/jtm\/taab180.","journal-title":"J Travel Med"},{"issue":"3","key":"784_CR55","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3201\/eid2803.212318","volume":"28","author":"A Fox-Lewis","year":"2022","unstructured":"Fox-Lewis A, Williamson F, Harrower J, et al. Airborne transmission of SARS-CoV-2 Delta variant within tightly monitored isolation facility, New Zealand (Aotearoa). Emerg Infect Dis. 2022;28(3):501\u20139. https:\/\/doi.org\/10.3201\/eid2803.212318.","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"784_CR56","doi-asserted-by":"publisher","first-page":"taaa088","DOI":"10.1093\/jtm\/taaa088","volume":"27","author":"S Qiu","year":"2020","unstructured":"Qiu S, Liu H, Li P, et al. Familial cluster of SARS-CoV-2 infection associated with a railway journey. J Travel Med. 2020;27(5):taaa088. https:\/\/doi.org\/10.1093\/jtm\/taaa088.","journal-title":"J Travel Med"},{"issue":"8","key":"784_CR57","doi-asserted-by":"publisher","first-page":"taab157","DOI":"10.1093\/jtm\/taab157","volume":"28","author":"S Benenson","year":"2021","unstructured":"Benenson S, Ottolenghi M, Cohen MJ, Nir-Paz R, Oster Y. High attack rate of COVID-19 in an organized tour group of vaccinated travellers to Iceland. J Travel Med. 2021;28(8):taab157. https:\/\/doi.org\/10.1093\/jtm\/taab157.","journal-title":"J Travel Med"},{"issue":"8","key":"784_CR58","doi-asserted-by":"publisher","first-page":"taab111","DOI":"10.1093\/jtm\/taab111","volume":"28","author":"Y Tsuchihashi","year":"2021","unstructured":"Tsuchihashi Y, Yamagishi T, Suzuki M, et al. High attack rate of SARS-CoV-2 infections during a bus tour in Japan. J Travel Med. 2021;28(8):taab111. https:\/\/doi.org\/10.1093\/jtm\/taab111.","journal-title":"J Travel Med"},{"issue":"7","key":"784_CR59","doi-asserted-by":"publisher","first-page":"taab098","DOI":"10.1093\/jtm\/taab098","volume":"28","author":"B Amatya","year":"2021","unstructured":"Amatya B, Pandey P, Dawadi S, Manandhar S. COVID-19 in fully vaccinated Everest trekkers in Nepal. J Travel Med. 2021;28(7):taab098. https:\/\/doi.org\/10.1093\/jtm\/taab098.","journal-title":"J Travel Med"},{"issue":"3","key":"784_CR60","doi-asserted-by":"publisher","first-page":"e1009374","DOI":"10.1371\/journal.ppat.1009374","volume":"17","author":"M Stange","year":"2021","unstructured":"Stange M, Mari A, Roloff T, et al. SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event. PLoS Pathog. 2021;17(3):e1009374. https:\/\/doi.org\/10.1371\/journal.ppat.1009374.","journal-title":"PLoS Pathog"},{"issue":"6529","key":"784_CR61","doi-asserted-by":"publisher","first-page":"eabe3261","DOI":"10.1126\/science.abe3261","volume":"371","author":"JE Lemieux","year":"2021","unstructured":"Lemieux JE, Siddle KJ, Shaw BM, et al. Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events. Science. 2021;371(6529):eabe3261. https:\/\/doi.org\/10.1126\/science.abe3261.","journal-title":"Science"},{"issue":"9","key":"784_CR62","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.3201\/eid2609.201469","volume":"26","author":"D Yusef","year":"2020","unstructured":"Yusef D, Hayajneh W, Awad S, et al. Large outbreak of coronavirus disease among wedding attendees. Jordan Emerg Infect Dis. 2020;26(9):2165\u20137. https:\/\/doi.org\/10.3201\/eid2609.201469.","journal-title":"Jordan Emerg Infect Dis"},{"issue":"8","key":"784_CR63","doi-asserted-by":"publisher","first-page":"taab160","DOI":"10.1093\/jtm\/taab160","volume":"28","author":"S Shukla","year":"2021","unstructured":"Shukla S, Khan R, Ahmed Y, Memish ZA. Conducting mass gathering events during the COVID-19 pandemic: a case study of Kumbh Mela 2021 as a potential \u2018super spreader event.\u2019 J Travel Med. 2021;28(8):taab160. https:\/\/doi.org\/10.1093\/jtm\/taab160.","journal-title":"J Travel Med"},{"issue":"4","key":"784_CR64","doi-asserted-by":"publisher","first-page":"e13743","DOI":"10.1111\/eci.13743","volume":"52","author":"S Cuschieri","year":"2022","unstructured":"Cuschieri S, Grech S, Cuschieri A. An observational study of the Covid-19 situation following the first pan-European mass sports event. Eur J Clin Invest. 2022;52(4):e13743. https:\/\/doi.org\/10.1111\/eci.13743.","journal-title":"Eur J Clin Invest"},{"issue":"7","key":"784_CR65","doi-asserted-by":"publisher","first-page":"243","DOI":"10.15585\/mmwr.mm7107a4","volume":"71","author":"S Sami","year":"2022","unstructured":"Sami S, Horter L, Valencia D, et al. Investigation of SARS-CoV-2 transmission associated with a large indoor convention - New York City, November-December 2021. MMWR Morb Mortal Wkly Rep. 2022;71(7):243\u20138. https:\/\/doi.org\/10.15585\/mmwr.mm7107a4.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"784_CR66","doi-asserted-by":"publisher","unstructured":"Smith-Jeffcoat SE, Pomeroy MA, Sleweon S, et al. Multistate outbreak of SARS-CoV-2 B.1.1.529 (Omicron) variant infections among persons in a social network attending a convention - New York City, November 18-December 20, 2021. MMWR Morb Mortal Wkly Rep. 2022;71(7):238\u201342. https:\/\/doi.org\/10.15585\/mmwr.mm7107a3.","DOI":"10.15585\/mmwr.mm7107a3"},{"issue":"8","key":"784_CR67","doi-asserted-by":"publisher","first-page":"taaa193","DOI":"10.1093\/jtm\/taaa193","volume":"27","author":"N Aggarwal","year":"2020","unstructured":"Aggarwal N, Garg M, Dwarakanathan V, et al. Diagnostic accuracy of non-contact infrared thermometers and thermal scanners: a systematic review and meta-analysis. J Travel Med. 2020;27(8):taaa193. https:\/\/doi.org\/10.1093\/jtm\/taaa193.","journal-title":"J Travel Med"},{"issue":"22","key":"784_CR68","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1056\/NEJMoa2008457","volume":"382","author":"MM Arons","year":"2020","unstructured":"Arons MM, Hatfield KM, Reddy SC, et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med. 2020;382(22):2081\u201390. https:\/\/doi.org\/10.1056\/NEJMoa2008457.","journal-title":"N Engl J Med"},{"issue":"28","key":"784_CR69","doi-asserted-by":"publisher","first-page":"904","DOI":"10.15585\/mmwr.mm6928a2","volume":"69","author":"RM Burke","year":"2020","unstructured":"Burke RM, Killerby ME, Newton S, et al. Symptom profiles of a convenience sample of patients with COVID-19 - United States, January-April 2020. MMWR Morb Mortal Wkly Rep. 2020;69(28):904\u20138. https:\/\/doi.org\/10.15585\/mmwr.mm6928a2.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"784_CR70","doi-asserted-by":"publisher","first-page":"taac043","DOI":"10.1093\/jtm\/taac043","volume":"29","author":"C Guest","year":"2022","unstructured":"Guest C, Dewhirst SY, Lindsay SW, et al. Using trained dogs and organic semi-conducting sensors to identify asymptomatic and mild SARS-CoV-2 infections: an observational study. J Travel Med. 2022;29(3):taac043. https:\/\/doi.org\/10.1093\/jtm\/taac043.","journal-title":"J Travel Med"},{"issue":"5","key":"784_CR71","doi-asserted-by":"publisher","first-page":"e008024","DOI":"10.1136\/bmjgh-2021-008024","volume":"7","author":"A Kantele","year":"2022","unstructured":"Kantele A, Paajanen J, Turunen S, et al. Scent dogs in detection of COVID-19: triple-blinded randomised trial and operational real-life screening in airport setting. BMJ Glob Health. 2022;7(5):e008024. https:\/\/doi.org\/10.1136\/bmjgh-2021-008024.","journal-title":"BMJ Glob Health"},{"issue":"7","key":"784_CR72","doi-asserted-by":"publisher","first-page":"taab116","DOI":"10.1093\/jtm\/taab116","volume":"28","author":"S Schneitler","year":"2021","unstructured":"Schneitler S, G\u00fclker J, Alhussein F, et al. Experiences with pre-travel diagnostic PCR testing for SARS-CoV-2: challenges and opportunities. J Travel Med. 2021;28(7):taab116. https:\/\/doi.org\/10.1093\/jtm\/taab116.","journal-title":"J Travel Med"},{"issue":"8","key":"784_CR73","doi-asserted-by":"publisher","first-page":"taaa141","DOI":"10.1093\/jtm\/taaa141","volume":"27","author":"BL Dickens","year":"2020","unstructured":"Dickens BL, Koo JR, Lim JT, et al. Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel. J Travel Med. 2020;27(8):taaa141. https:\/\/doi.org\/10.1093\/jtm\/taaa141.","journal-title":"J Travel Med"},{"issue":"10318","key":"784_CR74","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/S0140-6736(21)02752-5","volume":"398","author":"M Mendelson","year":"2021","unstructured":"Mendelson M, Venter F, Moshabela M, et al. The political theatre of the UK\u2019s travel ban on South Africa. Lancet. 2021;398(10318):2211\u20133. https:\/\/doi.org\/10.1016\/S0140-6736(21)02752-5.","journal-title":"Lancet"},{"key":"784_CR75","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ijid.2022.02.045","volume":"118","author":"E Layer","year":"2022","unstructured":"Layer E, Hoehl S, Widera M, et al. SARS-CoV-2 screening strategies for returning international travellers: evaluation of a rapid antigen test approach. Int J Infect Dis. 2022;118:126\u201331. https:\/\/doi.org\/10.1016\/j.ijid.2022.02.045.","journal-title":"Int J Infect Dis"},{"issue":"8","key":"784_CR76","doi-asserted-by":"publisher","first-page":"taaa184","DOI":"10.1093\/jtm\/taaa184","volume":"27","author":"K Sharun","year":"2020","unstructured":"Sharun K, Tiwari R, Natesan S, Yatoo MI, Malik YS, Dhama K. International travel during the COVID-19 pandemic: implications and risks associated with \u2018travel bubbles.\u2019 J Travel Med. 2020;27(8):taaa184. https:\/\/doi.org\/10.1093\/jtm\/taaa184.","journal-title":"J Travel Med"},{"issue":"4","key":"784_CR77","doi-asserted-by":"publisher","first-page":"511","DOI":"10.7326\/M20-6625","volume":"174","author":"T Czypionka","year":"2021","unstructured":"Czypionka T, Greenhalgh T, Bassler D, Bryant MB. Masks and face coverings for the lay public: a narrative update. Ann Intern Med. 2021;174(4):511\u201320. https:\/\/doi.org\/10.7326\/M20-6625.","journal-title":"Ann Intern Med"},{"issue":"10242","key":"784_CR78","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/S0140-6736(20)31142-9","volume":"395","author":"DK Chu","year":"2020","unstructured":"Chu DK, Akl EA, Duda S, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395(10242):1973\u201387. https:\/\/doi.org\/10.1016\/S0140-6736(20)31142-9.","journal-title":"Lancet"},{"key":"784_CR79","doi-asserted-by":"publisher","unstructured":"Brooks JT, Beezhold DH, Noti JD, et al. Maximizing fit for cloth and medical procedure masks to improve performance and reduce SARS-CoV-2 transmission and exposure, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(7):254\u20137. https:\/\/doi.org\/10.15585\/mmwr.mm7007e1.","DOI":"10.15585\/mmwr.mm7007e1"},{"key":"784_CR80","doi-asserted-by":"publisher","unstructured":"\u2022 Freedman DO, Wilder-Smith A. In-flight transmission of SARS-CoV-2: a review of the attack rates and available data on the efficacy of face masks. J Travel Med. 2020;27(8):taaa178. https:\/\/doi.org\/10.1093\/jtm\/taaa178. Perspective on the role of face masks in preventing transmission of SARS-CoV-2 aboard commercial aircraft.","DOI":"10.1093\/jtm\/taaa178"},{"key":"784_CR81","doi-asserted-by":"publisher","first-page":"102313","DOI":"10.1016\/j.tmaid.2022.102313","volume":"47","author":"S Namilae","year":"2022","unstructured":"Namilae S, Wu Y, Mubayi A, Srinivasan A, Scotch M. Identifying mitigation strategies for COVID-19 superspreading on flights using models that account for passenger movement. Travel Med Infect Dis. 2022;47:102313. https:\/\/doi.org\/10.1016\/j.tmaid.2022.102313.","journal-title":"Travel Med Infect Dis"},{"issue":"4","key":"784_CR82","doi-asserted-by":"publisher","first-page":"taab018","DOI":"10.1093\/jtm\/taab018","volume":"28","author":"S Sammito","year":"2021","unstructured":"Sammito S, M\u00fcller GPJ, Erley OM, Werner A. Impact of in-flight use of FFP2 masks on oxygen saturation: an experimental crossover study. J Travel Med. 2021;28(4):taab018. https:\/\/doi.org\/10.1093\/jtm\/taab018.","journal-title":"J Travel Med"},{"key":"784_CR83","doi-asserted-by":"publisher","unstructured":"Dietrich WL, Bennett JS, Jones BW, Hosni MH. Laboratory modeling of SARS-CoV-2 exposure reduction through physically distanced seating in aircraft cabins using bacteriophage aerosol - November 2020. MMWR Morb Mortal Wkly Rep. 2021;70(16):595\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm7016e1.","DOI":"10.15585\/mmwr.mm7016e1"},{"issue":"3","key":"784_CR84","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/cid\/ciab433","volume":"74","author":"SAJ Guagliardo","year":"2022","unstructured":"Guagliardo SAJ, Prasad PV, Rodriguez A, et al. Cruise ship travel in the era of coronavirus disease 2019 (COVID-19): a summary of outbreaks and a model of public health interventions. Clin Infect Dis. 2022;74(3):490\u20137. https:\/\/doi.org\/10.1093\/cid\/ciab433.","journal-title":"Clin Infect Dis"},{"key":"784_CR85","unstructured":"Centers for Disease Control and Prevention. Technical instructions for CDC\u2019s COVID-19 program for cruise ships operating in U.S. waters. 2022. Available at: https:\/\/www.cdc.gov\/quarantine\/cruise\/management\/technical-instructions-for-cruise-ships.html. (last accessed 27 June 2022)."},{"issue":"20","key":"784_CR86","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","volume":"383","author":"LA Jackson","year":"2020","unstructured":"Jackson LA, Anderson EJ, Rouphael NG, et al. An mRNA vaccine against SARS-CoV-2 - preliminary report. N Engl J Med. 2020;383(20):1920\u201331. https:\/\/doi.org\/10.1056\/NEJMoa2022483.","journal-title":"N Engl J Med"},{"issue":"27","key":"784_CR87","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315. https:\/\/doi.org\/10.1056\/NEJMoa2034577.","journal-title":"N Engl J Med"},{"key":"784_CR88","doi-asserted-by":"publisher","unstructured":"Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021 9;397(10269):99\u2013111. https:\/\/doi.org\/10.1016\/S0140-6736(20)32661-1. Epub 2020 Dec 8. Erratum in: Lancet. 2021 Jan 9;397(10269):98.","DOI":"10.1016\/S0140-6736(20)32661-1"},{"issue":"23","key":"784_CR89","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","volume":"384","author":"J Sadoff","year":"2021","unstructured":"Sadoff J, Gray G, Vandebosch A, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. 2021;384(23):2187\u2013201. https:\/\/doi.org\/10.1056\/NEJMoa2101544.","journal-title":"N Engl J Med"},{"key":"784_CR90","unstructured":"World Health Organization. COVID-19 vaccines with WHO Emergency Use Listing. 2022. Available at: https:\/\/extranet.who.int\/pqweb\/vaccines\/vaccinescovid-19-vaccine-eul-issued. (last accessed 27 June 2022)."},{"issue":"2","key":"784_CR91","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1056\/NEJMsr2105280","volume":"385","author":"PR Krause","year":"2021","unstructured":"\u2022\u2022 Krause PR, Fleming TR, Longini IM, et al. SARS-CoV-2 variants and vaccines. N Engl J Med. 2021;385(2):179\u201386. https:\/\/doi.org\/10.1056\/NEJMsr2105280. Special report about the emergence of SARS-CoV-2 variants of concern and their response to currently available vaccines.","journal-title":"N Engl J Med"},{"issue":"3","key":"784_CR92","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/s41591-022-01728-z","volume":"28","author":"E Pertwee","year":"2022","unstructured":"Pertwee E, Simas C, Larson HJ. An epidemic of uncertainty: rumors, conspiracy theories and vaccine hesitancy. Nat Med. 2022;28(3):456\u20139. https:\/\/doi.org\/10.1038\/s41591-022-01728-z.","journal-title":"Nat Med"},{"issue":"4","key":"784_CR93","doi-asserted-by":"publisher","first-page":"taab048","DOI":"10.1093\/jtm\/taab048","volume":"28","author":"AF Crawshaw","year":"2021","unstructured":"Crawshaw AF, Deal A, Rustage K, et al. What must be done to tackle vaccine hesitancy and barriers to COVID-19 vaccination in migrants? J Travel Med. 2021;28(4):taab048. https:\/\/doi.org\/10.1093\/jtm\/taab048.","journal-title":"J Travel Med"},{"issue":"22","key":"784_CR94","doi-asserted-by":"publisher","first-page":"00066","DOI":"10.1016\/S1473-3099(22)00066-4","volume":"S1473\u20133099","author":"AF Crawshaw","year":"2022","unstructured":"Crawshaw AF, Farah Y, Deal A, et al. Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: a systematic review. Lancet Infect Dis. 2022;S1473\u20133099(22):00066\u201374. https:\/\/doi.org\/10.1016\/S1473-3099(22)00066-4.","journal-title":"Lancet Infect Dis"},{"key":"784_CR95","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ijid.2021.02.061","volume":"105","author":"C Franco-Paredes","year":"2021","unstructured":"Franco-Paredes C, Suarez JA, Henao-Mart\u00ednez AF. Global COVID-19 vaccine equity should precede requiring travelers proof of vaccination. Int J Infect Dis. 2021;105:243\u20134. https:\/\/doi.org\/10.1016\/j.ijid.2021.02.061.","journal-title":"Int J Infect Dis"},{"key":"784_CR96","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116620","author":"MJ Levin","year":"2022","unstructured":"\u2022\u2022 Levin MJ, Ustianowski A, De Wit S, et al. Intramuscular AZD7442 (tixagevimab-cilgavimab) for prevention of Covid-19. N Engl J Med. 2022. https:\/\/doi.org\/10.1056\/NEJMoa2116620. Phase 3 trial of the efficacy of a monoclonal antibody combination in the prevention of COVID-19.","journal-title":"N Engl J Med"},{"key":"784_CR97","doi-asserted-by":"publisher","first-page":"M22","DOI":"10.7326\/M22-1026","volume":"12","author":"CN Kotton","year":"2022","unstructured":"Kotton CN. Belt and suspenders: vaccines and tixagevimab\/cilgavimab for prevention of COVID-19 in immunocompromised patients. Ann Intern Med. 2022;12:M22-1026. https:\/\/doi.org\/10.7326\/M22-1026.","journal-title":"Ann Intern Med"},{"issue":"15","key":"784_CR98","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","volume":"386","author":"J Hammond","year":"2022","unstructured":"Hammond J, Leister-Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med. 2022;386(15):1397\u2013408. https:\/\/doi.org\/10.1056\/NEJMoa2118542.","journal-title":"N Engl J Med"},{"issue":"6","key":"784_CR99","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa2116044","volume":"386","author":"A Jayk Bernal","year":"2022","unstructured":"Jayk Bernal A, Gomes da Silva MM, Musungaie DB, et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N Engl J Med. 2022;386(6):509\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2116044.","journal-title":"N Engl J Med"},{"key":"784_CR100","unstructured":"U.S. National Library of Medicine. Phase III double-blind, placebo-controlled study of AZD7442 for pre-exposure prophylaxis of COVID-19 in adult. (PROVENT). 2022. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04625725. (last accessed 25 June 2022)."},{"issue":"13","key":"784_CR101","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1001\/jama.2022.3382","volume":"327","author":"EY Adashi","year":"2022","unstructured":"Adashi EY, Cohen IG. SARS-CoV-2 laboratory-developed tests: integrity restored. JAMA. 2022;327(13):1229\u201330. https:\/\/doi.org\/10.1001\/jama.2022.3382.","journal-title":"JAMA"},{"issue":"3","key":"784_CR102","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1001\/jama.2021.24394","volume":"327","author":"JB Nuzzo","year":"2022","unstructured":"Nuzzo JB, Gostin LO. The first 2 years of COVID-19: lessons to improve preparedness for the next pandemic. JAMA. 2022;327(3):217\u20138. https:\/\/doi.org\/10.1001\/jama.2021.24394.","journal-title":"JAMA"},{"issue":"8","key":"784_CR103","doi-asserted-by":"publisher","first-page":"taab143","DOI":"10.1093\/jtm\/taab143","volume":"28","author":"F Gobbi","year":"2021","unstructured":"Gobbi F, Noharet R, Abreu C, Del Mar Lago Nu\u00f1ez M, Canale A, O\u00f1orbe MF, Mu\u00f1oz J, Rossanese A, Atouguia J. South Europe perspective of COVID-19 impact on travel medicine. J Travel Med. 2021;28(8):taab143. https:\/\/doi.org\/10.1093\/jtm\/taab143.","journal-title":"J Travel Med"},{"key":"784_CR104","doi-asserted-by":"publisher","first-page":"100041","DOI":"10.1016\/j.jmh.2021.100041","volume":"3","author":"SE Hayward","year":"2021","unstructured":"Hayward SE, Deal A, Cheng C, et al. Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: a systematic review. J Migr Health. 2021;3:100041. https:\/\/doi.org\/10.1016\/j.jmh.2021.100041.","journal-title":"J Migr Health"},{"key":"784_CR105","unstructured":"Centers for Disease Control and Prevention. COVID-19 travel recommendations by destination. 2022. Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/travelers\/map-and-travel-notices.html. (last accessed 27 June 2022)."},{"key":"784_CR106","unstructured":"World Tourism Organization. UNWTO\/IATA Destination Tracker \u2013 Easy Travel. 2022. Available at: https:\/\/www.unwto.org\/tourism-data\/unwto-iata-destination-tracker-easy-travel. (last accessed 27 June 2022)."},{"issue":"8","key":"784_CR107","doi-asserted-by":"publisher","first-page":"taaa219","DOI":"10.1093\/jtm\/taaa219","volume":"27","author":"DH Hamer","year":"2020","unstructured":"Hamer DH, Rizwan A, Freedman DO, Kozarsky P, Libman M. GeoSentinel: past, present and future\u2020. J Travel Med. 2020;27(8):taaa219. https:\/\/doi.org\/10.1093\/jtm\/taaa219.","journal-title":"J Travel Med"},{"key":"784_CR108","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40794-020-00118-y","volume":"6","author":"GT Flaherty","year":"2020","unstructured":"\u2022 Flaherty GT, Hession P, Liew CH, et al. COVID-19 in adult patients with pre-existing chronic cardiac, respiratory and metabolic disease: a critical literature review with clinical recommendations. Trop Dis Travel Med Vaccines. 2020;6:16. https:\/\/doi.org\/10.1186\/s40794-020-00118-y. Comprehensive review of the impact of COVID-19 on travellers with chronic illness.","journal-title":"Trop Dis Travel Med Vaccines"},{"issue":"1","key":"784_CR109","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12889-020-10126-4","volume":"21","author":"MA Carrillo","year":"2021","unstructured":"Carrillo MA, Kroeger A, Cardenas Sanchez R, Diaz Monsalve S, Runge-Ranzinger S. The use of mobile phones for the prevention and control of arboviral diseases: a scoping review. BMC Public Health. 2021;21(1):110. https:\/\/doi.org\/10.1186\/s12889-020-10126-4.","journal-title":"BMC Public Health"},{"issue":"5","key":"784_CR110","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.14202\/vetworld.2022.1237-1245","volume":"15","author":"IM Subrata","year":"2022","unstructured":"Subrata IM, Harjana NPA, Agustina KK, Purnama SG, Kardiwinata MP. Designing a rabies control mobile application for a community-based rabies surveillance system during the COVID-19 pandemic in Bali. Indonesia Vet World. 2022;15(5):1237\u201345. https:\/\/doi.org\/10.14202\/vetworld.2022.1237-1245.","journal-title":"Indonesia Vet World"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-022-00784-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11908-022-00784-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-022-00784-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T08:33:52Z","timestamp":1663662832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11908-022-00784-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":110,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["784"],"URL":"https:\/\/doi.org\/10.1007\/s11908-022-00784-3","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]},"assertion":[{"value":"25 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Flaherty has received conference registration support as an Executive Board member of the Travel Medicine Society of Ireland (former) and International Society of Travel Medicine (current). Dr. Chen reports honoraria from Shoreland Inc, Valneva, Takeda, Sanofi-Pasteur, Emergent BioSolutions, and Merck. Dr. Hamer reports consulting fees and honoraria from Xenophon Strategies, Inc., Trinity Biotech, LLC, Equinox, Major League Soccer, PGA of America, Valneva, and Takeda.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}